Clinical trial
Insulin Secretion in Diabetes Before and After Glycemic Control
NCT00469833 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00469833 |
|---|---|
| Title | Insulin Secretion in Diabetes Before and After Glycemic Control |
| Official title | Pathogenesis of the Impaired Incretin Effect in Type 2 Diabetes |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes, Hyperglycemia |
| Intervention type | Drug |
| Interventions | insulin glargine |
| Enrollment | 17 |
| Start date | Apr 1, 2008 |
| Primary completion | Dec 1, 2011 |
| Completion | Sep 1, 2012 |
| First posted | May 7, 2007 |
| Last update posted | Jan 15, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: